Mindmore provides digitized tests that are used by primary and occupational health clinics to detect early signs of cognitive impairment among their patients. Universities also use the tests in research aimed at evaluating how various conditions affect cognitive status (brain health).
The tests have been validated in multiple scientific studies and give physicians, psychologists, and other health professionals an objective and resource-efficient way of identifying cognitive impairment associated with, for example, depression, burnout, and dementia.
Mindmore is a CE-marked medical device that is recommended by Socialstyrelsen (Sweden’s National Board of Health and Welfare) as a tool for cognitive assessment. The company is based in Stockholm, Sweden, and was founded by its current CEO, Sara Wallén, in 2017.
Read more at Mindmore.com